Vedsted, P., Åbom, B.
, Neergaard, M. A. & Maagaard, R., (2008).
Terminalforløb og palliation i almen praksis - Almen praksis rolle og indsats, 14 p., Mar 06, 2008.
Lundby, C., Achman-Andersen, N. J.
, Thomsen, J. J., Norgaard, A. M. & Robach, P. (2008).
Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing.
Journal of Applied Physiology,
105(2), 417-9.
https://doi.org/10.1152/japplphysiol.90529.2008
Grarup, N., Andreasen, C. H.
, Andersen, M. K., Albrechtsen, A.
, Sandbaek, A., Lauritzen, T., Borch-Johnsen, K.
, Jørgensen, T., Schmitz, O., Hansen, T. & Pedersen, O. (2008).
The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects.
Journal of Clinical Endocrinology and Metabolism,
93(6), 2294-9.
https://doi.org/10.1210/jc.2007-2815
Grarup, N., Andreasen, C. H., Andersen, M. K., Albrechtsen, A.
, Sandbæk, A., Lauritzen, T., Borch-Johnsen, K., Jørgensen, T.
, Schmitz, O., Hansen, T.
& Pedersen, O. B. (2008).
The -250G>A promoter variant in hepatic lipase (LIPC) associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects.
Journal of Clinical Endocrinology and Metabolism,
93(6), 2294-9.
Robach, P., Calbet, J. A. L., Thomsen, J. J., Boushel, R., Mollard, P., Rasmussen, P.
& Lundby, C. (2008).
The ergogenic effect of recombinant human erythropoietin on VO2max depends on the severity of arterial hypoxemia.
PLoS One,
3(8), e2996.
https://doi.org/10.1371/journal.pone.0002996